Company

osteolabs GmbH

osteolabs GmbH, based in Kiel, Germany, makes CIM biomarker technology for measuring bone density changes.

About

Founded in 2018 and headquartered in Kiel, Germany, osteolabs GmbH develops diagnostics for bone health. Its CIM biomarker technology measures changes in bone density and helps assess metabolic bone diseases such as osteoporosis, with customers including hospitals and research institutions in Europe and North America. In June 2019 the company raised SEED funding from Laboratory Dr. Krause & Kollegen MVZ GmbH, MBG Baden-Wurttemberg and other investors.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in